Lupin launches Ganirelix Acetate injection in US

Lupin Ltd has launched the Ganirelix Acetate injection, a single-dose prefilled syringe approved by the US FDA, for women undergoing fertility treatments. The injection, a generic equivalent to Organon USA LLC, is used to inhibit premature Luteinizing Hormone surges. It has an estimated annual sales of USD 87 million in the US.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news